Affymetrix is at the forefront of a scientific revolution. The genetic information gathered by scientists today is changing the healthcare of tomorrow by informing both the diagnostic and treatment processes. This information helps us understand disease at the molecular level and allows doctors to customize treatments based on an individual's genetic makeup. One day, genetic-based disease prevention and cures may be possible, and Affymetrix' whole-genome technologies and tools will play a key role in that transformation.

Affymetrix GeneChip® technology combines semiconductor manufacturing techniques with combinatorial chemistry to provide scientists and clinicians with the most comprehensive genetic information possible. Since its founding in 1991, Affymetrix has continued to break new ground. Our tools and services are speeding discovery and leading to better treatments in research labs and in clinical practice. Affymetrix technology is the gold standard in genetic analysis across virtually every life sciences sector.

We strategically partner with leading academic researchers, as well as pharmaceutical and biotechnology companies, to provide our customers with a complete and seamless solution to address all of their microarray research and analytical needs. Affymetrix' mission is to be the leading source of genetic technologies to better understand and improve the quality of life.